Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,903 | -21,760 | -15,717 | -10,868 | -7,316 |
| Depreciation Amortization | 46 | 201 | 151 | 104 | 51 |
| Accounts payable and accrued liabilities | 250 | 799 | 1,534 | -90 | 173 |
| Other Working Capital | -1,740 | 3,255 | 1,757 | 1,051 | 1,771 |
| Other Operating Activity | 283 | 770 | -246 | 903 | 121 |
| Operating Cash Flow | $-6,064 | $-16,735 | $-12,521 | $-8,900 | $-5,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,803 | 19,658 | -2,481 | 14,300 | 20,300 |
| PPE Investments | -3 | -26 | -26 | -20 | -14 |
| Net Acquisitions | -3,549 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | 160 | 14,300 | -2,482 | -2,500 |
| Purchase Sale Intangibles | N/A | -202 | -202 | -203 | -203 |
| Other Investing Activity | 352 | 122 | 122 | -60 | -70 |
| Investing Cash Flow | $12,603 | $19,914 | $11,915 | $11,738 | $17,716 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 395 | 1,498 | 1,312 | 653 | 230 |
| Other Financing Activity | -131 | -384 | -287 | -197 | -68 |
| Financing Cash Flow | $264 | $1,114 | $1,025 | $456 | $162 |
| Exchange Rate Effect | 50 | -153 | -235 | -178 | -31 |
| Beginning Cash Position | 15,030 | 10,890 | 10,890 | 10,890 | 10,890 |
| End Cash Position | 21,883 | 15,030 | 11,074 | 14,006 | 23,537 |
| Net Cash Flow | $6,853 | $4,140 | $184 | $3,116 | $12,647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,064 | -16,735 | -12,521 | -8,900 | -5,200 |
| Capital Expenditure | -3 | -26 | -26 | -20 | -14 |
| Free Cash Flow | -6,067 | -16,761 | -12,547 | -8,920 | -5,214 |